miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1
Keywords: miR-505; HMGB1; Doxorubicin; γH2AX; Akt pathway; Hepatocellular carcinoma;